{"id":"W2149472508","doi":"10.1007/s10637-007-9090-3","title":"A phase 1 study of SNS-032 (formerly BMS-387032), a potent inhibitor of cyclin-dependent kinases 2, 7 and 9 administered as a single oral dose and weekly infusion in patients with metastatic refractory solid tumors","year":2007,"lang":"en","type":"article","venue":"Investigational New Drugs","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pyrogenesis (Canada)","funders":"","keywords":"Pharmacokinetics; Cmax; Medicine; Tolerability; Bioavailability; Nausea; Adverse effect; Pharmacology; Pharmacodynamics; Maximum tolerated dose; Cyclin-dependent kinase; Dysgeusia; Toxicity; Refractory (planetary science); Oral administration; Internal medicine; Cancer; Cell cycle","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002651473,0.0002332769,0.0005150862,0.000320833,0.00004410428,0.00001171183,0.00006114042,0.00004369171,0.00001940673],"category_scores_gemma":[0.0001732399,0.0001914081,0.00002964168,0.0002742355,0.0003147099,0.0002669471,0.00005670627,0.0001594493,8.600413e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001169715,"about_ca_system_score_gemma":0.0003916759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004618927,"about_ca_topic_score_gemma":0.0002173437,"domain_scores_codex":[0.9979231,0.0000593974,0.0007305066,0.0003297668,0.0007341933,0.0002230624],"domain_scores_gemma":[0.9986618,0.0001585688,0.0004689942,0.0001868535,0.0002221084,0.0003017165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.04251535,0.03188136,0.5890997,0.0009556744,0.0007533231,0.0003367946,0.05403939,0.0001630507,0.1017863,0.0002255556,0.00005582016,0.1781877],"study_design_scores_gemma":[0.07007293,0.03068002,0.8636373,0.001475278,0.0002843017,0.00007953712,0.01015793,0.00005233263,0.02121229,0.001830064,0.00009743703,0.0004205737],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984275,0.0001860421,0.00002765666,0.0002217094,0.00003795378,0.001001688,0.00003499659,0.00001656032,0.0000459465],"genre_scores_gemma":[0.9965206,0.000003258761,0.003044,0.000232081,0.00003837705,0.00001808957,0.00004956705,0.00002880197,0.00006521206],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2745376,"threshold_uncertainty_score":0.7805396,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02381757120153434,"score_gpt":0.3125895757310258,"score_spread":0.2887720045294915,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}